NON SMALL CELL LUNG CANCER NSCLC

This early-phase trial looked at combining a special type of radiation (hypofractionated radiotherapy) with two immunotherapy drugs (MEDI4736 and tremelimumab) for people with advanced melanoma, lung, breast, or pancreatic cancer that had spread. The main goal was to find the saf…

This study tested whether adding tiragolumab to atezolizumab (both immunotherapy drugs) works better than atezolizumab alone in people with a certain type of lung cancer (PD-L1 positive non-small cell lung cancer) who had surgery and chemotherapy. The trial enrolled 56 adults wit…

This study tested an oral drug called capmatinib in 36 Chinese adults with advanced non-small cell lung cancer that has a specific MET gene mutation. The drug aims to block signals that help cancer grow, potentially keeping the disease under control. Participants had not received…

This study looked back at medical records of 70 adults in Argentina with a certain type of lung cancer (non-small cell lung cancer) that could be removed with surgery. All patients received a combination of the immunotherapy drug nivolumab and chemotherapy before their surgery. T…

This study tested a new drug combination (tiragolumab plus atezolizumab and chemotherapy) against a standard treatment (pembrolizumab plus chemotherapy) in 542 people with advanced non-squamous lung cancer who had not received prior treatment. The goal was to see if the new combo…

This study tested a new approach for people with advanced non-small cell lung cancer whose tumors have high levels of a protein called PD-L1. Instead of standard chemotherapy plus radiation, participants received immunotherapy (pembrolizumab) followed by a personalized 4-week cou…

This study tested a daily pill called osimertinib in 73 people with a specific type of lung cancer that had spread to the lining of the brain. The goal was to see if the drug could shrink these tumors and help people live longer. Participants took the medication once a day, and r…

This study tested whether a combination of two immunotherapy drugs (atezolizumab and tiragolumab) works better than the standard drug (durvalumab) for people with stage III lung cancer that cannot be removed by surgery. Participants had already received chemotherapy and radiation…

This study tested whether small implanted beacons (Calypso) can help doctors track lung tumors during radiation while patients hold their breath. 48 adults with lung cancer took part. The goal was to see if this approach is feasible and improves treatment accuracy.

This study looked at whether changing how PET/CT scans are taken can give clearer images of lung cancer spread. Thirty adults with non-small cell lung cancer had extra scan time to test different settings. The goal was to see if these adjustments help doctors stage the disease mo…